SS
TNYA icon

SBI Securities’s Tenaya Therapeutics TNYA Stock Holding History

SBI Securities’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$542 Hold
783
– – ﹤0.01% 2866
2025
Q4 		$557 Sell
783
-701
-47% -$953 ﹤0.01% 2833
2025
Q3 		$2.4K Sell
1,484
-99
-6% -$100 ﹤0.01% 2350
2025
Q2 		$968 Hold
1,583
– – ﹤0.01% 2696
2025
Q1 		$902 Hold
1,583
– – ﹤0.01% 2626
2024
Q4 		$2.26K Buy
+1,583
New +$3.55K ﹤0.01% 2259

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SBI Securities's TNYA Position: Q1 2026 in Review

SBI Securities held its Tenaya Therapeutics (TNYA) position steady in Q1 2026 at 783 shares worth $542. The position accounts for ﹤0.01% of the portfolio, ranked #2866.

SBI Securities first reported a position in TNYA in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.4K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • SBI Securities held 783 shares of Tenaya Therapeutics worth $542 as of Q1 2026.
  • SBI Securities left its Tenaya Therapeutics share count unchanged in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2866 holding.
  • SBI Securities first reported a position in Tenaya Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Tenaya Therapeutics position peaked at $2.4K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.